HYBRIGENICS
Hybrigenics Pharma is a bio-pharmaceutical company with a focus on research and development of new targets and therapies against cancer.Hybrigenics Pharma has stopped the development of inecalcitol, a vitamin D receptor agonist.Hybrigenics Pharma's research program investigates the action of enzymes called Deubiquitinating Enzymes (DUBs) in the recycling of onco-proteins and the potential activity of proprietary patented DUB inhibitors against various cancer indications.
HYBRIGENICS
Industry:
Bioinformatics Biotechnology Therapeutics
Founded:
1998-01-01
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.hybrigenics.com
Total Employee:
51+
Status:
Active
Contact:
+33 (0) 158103800
Email Addresses:
[email protected]
Total Funding:
70.53 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Apache Microsoft Exchange Online
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Hookipa Pharma
Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2003-04-29 | Semaia Pharmaceuticals | Semaia Pharmaceuticals acquired by Hybrigenics | N/A |
Investors List
Crede CapitalGroup
Crede CapitalGroup investment in Post-IPO Equity - Hybrigenics
Life Sciences Partners
Life Sciences Partners investment in Post-IPO Equity - Hybrigenics
Pradeyrol Development
Pradeyrol Development investment in Post-IPO Equity - Hybrigenics
Pradeyrol Development
Pradeyrol Development investment in Post-IPO Equity - Hybrigenics
Yorkville Advisors
Yorkville Advisors investment in Post-IPO Equity - Hybrigenics
Medicis Capital
Medicis Capital investment in Series B - Hybrigenics
Auriga Partners
Auriga Partners investment in Series B - Hybrigenics
Apax Partners
Apax Partners investment in Series B - Hybrigenics
Lombard Odier
Lombard Odier investment in Series B - Hybrigenics
Alafi Capital
Alafi Capital investment in Series B - Hybrigenics
Official Site Inspections
http://www.hybrigenics.com Semrush global rank: 4.18 M Semrush visits lastest month: 2.83 K
- Host name: rhea.web-hebergement.net
- IP address: 46.105.61.161
- Location: France
- Latitude: 48.8582
- Longitude: 2.3387
- Timezone: Europe/Paris
